14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.32 $7.70 Tuesday, 16th Apr 2024 FATE stock ended at $5.38. This is 4.61% less than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 7.89% from a day low at $5.32 to a day high of $5.74.
90 days $4.10 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2023-12-27 $3.78 $3.94 $3.57 $3.66 2 034 882
2023-12-26 $3.49 $3.80 $3.43 $3.72 3 276 903
2023-12-22 $3.36 $3.68 $3.34 $3.42 1 380 828
2023-12-21 $3.13 $3.42 $3.11 $3.35 1 247 226
2023-12-20 $3.25 $3.38 $3.05 $3.06 1 420 536
2023-12-19 $3.17 $3.39 $3.09 $3.29 2 330 087
2023-12-18 $2.98 $3.55 $2.97 $3.15 3 194 064
2023-12-15 $3.03 $3.16 $2.99 $3.02 3 840 731
2023-12-14 $2.82 $3.02 $2.77 $2.98 3 335 318
2023-12-13 $2.40 $2.68 $2.31 $2.68 1 528 098
2023-12-12 $2.26 $2.40 $2.21 $2.40 1 032 536
2023-12-11 $2.21 $2.29 $2.10 $2.28 1 074 205
2023-12-08 $2.33 $2.41 $2.24 $2.24 783 644
2023-12-07 $2.43 $2.43 $2.29 $2.35 719 510
2023-12-06 $2.39 $2.50 $2.29 $2.40 1 250 603
2023-12-05 $2.51 $2.55 $2.35 $2.37 1 175 387
2023-12-04 $2.60 $2.70 $2.50 $2.54 968 163
2023-12-01 $2.51 $2.66 $2.30 $2.65 1 231 287
2023-11-30 $2.66 $2.71 $2.47 $2.49 2 839 696
2023-11-29 $2.60 $2.84 $2.58 $2.62 2 215 004
2023-11-28 $2.27 $2.55 $2.17 $2.53 1 726 820
2023-11-27 $2.36 $2.36 $2.20 $2.28 1 150 619
2023-11-24 $2.39 $2.49 $2.32 $2.36 466 692
2023-11-22 $2.48 $2.56 $2.37 $2.39 716 666
2023-11-21 $2.54 $2.55 $2.39 $2.45 1 276 567
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT